Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03199794 · ClinicalTrials.gov registry record
Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
A clinical trial, sponsored by Baxalta now part of Shire.
- Completed
- Registry status
- 50
- Enrollment target
NCT03199794 is a clinical trial that has completed, run by Baxalta now part of Shire. The registered enrollment target is 50 participants.
The verdict
NCT03199794 has completed, sponsored by Baxalta now part of Shire.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The study addresses the safety, utilisation and effectiveness of Obizur in the treatment of bleeding episodes in real-life clinical practice in Europe and the United States.
Interventions
- BIOLOGICAL OBIZUR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-12-14 |
| Est. Completion | 2021-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03199794
The ClinicalTrials.gov registry entry for NCT03199794 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxalta now part of Shire, which has 74 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OBIZUR is the first listed.
NCT03199794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03199794 about?
NCT03199794 is a clinical study titled "Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice". The study addresses the safety, utilisation and effectiveness of Obizur in the treatment of bleeding episodes in real-life clinical practice in Europe and the United States.
What is the current status of trial NCT03199794?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-12-14. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT03199794?
The interventions under investigation include: OBIZUR (BIOLOGICAL).
Who is sponsoring clinical trial NCT03199794?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.